0001415889-23-003045.txt : 20230222 0001415889-23-003045.hdr.sgml : 20230222 20230222183706 ACCESSION NUMBER: 0001415889-23-003045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230217 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN HUBERT L CENTRAL INDEX KEY: 0001565916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 23655203 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD, AP6C-1N CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02222023_110256.xml X0306 4 2023-02-17 0000001800 ABBOTT LABORATORIES ABT 0001565916 ALLEN HUBERT L 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT Common shares without par value 2023-02-17 4 A 0 18448 0 A 185543 D Option (right to buy) 106.24 2023-02-17 4 A 0 72754 0 A 2024-02-17 2033-02-16 Common Shares 72754 72754 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,251 on February 17, 2024, 24,251 on February 17, 2025, and 24,252 on February 17, 2026. /s/ Hubert L. Allen by Jessica H. Paik, Attorney-in-Fact 2023-02-22